Skip to main content
SpringerLink
Log in

A cellular model for drug interactions on hematopoiesis: The use of human umbilical cord blood progenitors as a model for the study of drug-related myelosuppression of normal hematopoiesis

  • Published:
Cell Biology and Toxicology Aims and scope Submit manuscript

Abstract

A cellular model of hematopoiesis which would be more convenient than bone marrow (BM) progenitors and directly relevant to human pathology is needed in order to investigate xenobiotic toxicity. Human umbilical cord blood (HCB), previously shown to be able to repopulate BM, provides a powerful in vitro model of normal human hematopoiesis. In order to validate the use of normal HCB progenitors as targets for dose-related myelosuppression, we used clonogenic assays and expansion in a liquid culture of progenitor-enriched cell suspensions from HCB. A series of 8 reference molecules, doxorubicin, cytosine-arabinoside, 5-fluorouracil, 3′-azido-3′-deoxythymidine, acetylsalicyclic acid, sodium valproate and two cephalosporin antibiotics, were tested. In vitro 50% inhibition concentrations (IC50) were compared to those observed or reported with BM progenitors, and to the values of plasma concentrations from treated patients. HCB progenitors as in vitro targets for cytotoxic molecules were easy to access and handle, and their use was sensitive, specific and reproducible. They gave results similar to BM progenitors and allowed a qualitative approach to cellular metabolism and toxicity using morphological, flow cytometric and chromatographic methods.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ARA-CC:

cytosine arabinoside

AS:

acetylsalicylic acid

AZTT:

3′-azido-3′-deoxythymidine

BFUU:

burst-forming units

BM:

bone marrow

CFU:

colony-forming units

DOXX:

doxorubicin

FU:

5-fluorouracil

glyAA:

glyAcophorin A

HCB:

human umbilical cord blood

IU:

international units

PCMEM:

human placenta-conditioned medium

VA:

sodium valproate

References

  • Abboud M, Fushen Xu, Lavia M, Laver J. Study of early hematopoietic precursors in human cord. Blood Cells. 1992;17:287–95.

    Google Scholar 

  • Ardiet C, Bastian G, Favre R et al. (eds) Guide pratique de pharmacocinétique clinique en oncologie. Paris: Frison Roche Ed; 1989.

    Google Scholar 

  • Aroch M, Dedenon A, Damais C, Averlant G, Guillosson JJ. Mise en évidence d'un effet protecteur de l'interleukine-1 vis à vis de la toxicité hématologique de l'azidothymidine (AZTT) CR Seances Soc Biol Fil. 1992; 186:206–14.

    Google Scholar 

  • Barberi-Heyob M, Merlin JL, Weber B. Dosage of the anabolites of 5-fluorouracil in patients presenting with advanced breast cancer. Proc Annu Meet Am Assoc Cancer Res. 1993;33:A3187.

    Google Scholar 

  • Bechmann RA, McFall PJ, Sikic BI, Smith SD. Doxorubinin and the alkylating anthracycline 3′-deamino-3′-(3-cyano-4 morpholinyl)doxorubicin: comparative in vitro potency against leukemia and bone marrow cells. J Natl Cancer Inst. 1988;80:361–5.

    Google Scholar 

  • Bender JG, Unverzagt KL, Walker DE et al. Identification and comparison of CD34 positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood. 1991;77:2591–6.

    Google Scholar 

  • Broxmeyer HE, Douglas GW, Hangoc G et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitors cells. Proc Natl Acad Sci USA. 1989;86:3828–32.

    Google Scholar 

  • Broxmeyer HE, Kurtzberg J, Gluckman E et al. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells. 1991;17:313–29.

    Google Scholar 

  • Caldwell J. Problems and opportunities in toxicity testing arising from species differences in xenobiotic metabolism. Toxicol Lett. 1992;64/65:651–9.

    Google Scholar 

  • Caux C, Favre C, Saeland Sem et al. Sequential loss of CD34 and class II MHC antigens on purified cord blood hematopoietic progenitors cultured with I13. Blood. 1989;74:1287–94.

    Google Scholar 

  • Civin CI, Strauss LC, Brovall C. Antigenic analysis of hematopoiesis III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KGM-1 a cell. J Immunol. 1984;133:157–65.

    Google Scholar 

  • Dainiak N, Worthington M, Riordan MA, Kreczko S, Goldman L. 3′-Azido-3′-deoxythymidine (AZTT) inhibits proliferation in vitro of human haematopoietic progenitor cells. Br J Haematol. 1988;69: 299–304.

    Google Scholar 

  • Darzynkiewicz Z, Bruno S, Delbino G et al. Features of apoptotic cells measured by flow cytometry. Cytometry. 1992;13:795–808.

    Google Scholar 

  • Deldar A, Stevens CE. Development and application of in vitro models of hematopoiesis to drug-development. Toxicol Pathol. 1993;21:231–40.

    Google Scholar 

  • De Lin D, Volpe DA, Grieshber CK, Murphy MJ. Effects of L-phenylalanine mustard and L-buthionine-sulfoximine on murine and human hematopoietic progenitor cells in vitro. Cancer Res. 1990;50:4038–43.

    Google Scholar 

  • Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modification to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Meth. 1986;89:271–7.

    Google Scholar 

  • Der Lely N, De Witte T, Muus P, Raymakers R, Preijers F, Haanen C. Prolonged exposure to cytosine-arabinoside in the presence of hematopoietic cytokines preferentially kills leukemic versus clonogenic cells. Exp Hematol. 1991;19:267–72.

    Google Scholar 

  • Dive C, Hickman JA. Drug target interactions: only the first step in the commitment to a programmed cell death. Br J Cancer. 1991;64:192–6.

    Google Scholar 

  • Fauser AA, Messner HA. Granulo-erythropoietic colony in human bone marrow, peripheral blood and cord blood. Blood. 1978;2:1243–7.

    Google Scholar 

  • Gallichio VS, Hughes N. Influence of interleukin-3 on Zidovudine (AZTT)-induced in vitro toxicity to human hematopoietic progenitors. Int J Cell Cloning. 1992;10:99–104.

    Google Scholar 

  • Gallichio VS, Hughes NK. Influence of interleukin-3 (IL3) on the hematopoietic toxicity associated with combination antiviral drugs (Zidovudine and DDI) in vitro using retro-virus-infected bone marrow cells. Int J Immunopharmacol. 1994;16:359–66.

    Google Scholar 

  • Ganser A, Greher J, Völkers B, Staszewski S, Hoelzer D. Inhibitory effect of azidothymidine, 2′,3′-dideoxyadenosine, and 2′,3′-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and patients with AIDS. Exp Hematol. 1989;17:321–5.

    Google Scholar 

  • Gluckman E, Broxmeyer HA, Averbach AD et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an Hla-identical sibling. N Engl J Med. 1989;321:1174–8.

    Google Scholar 

  • Gluckman E, Thierry D, Lesage D et al. Cord blood banking for human hematopoietic cell transplantation. Prog Clin Biol Res. 1992;377:591–9.

    Google Scholar 

  • Grant S, Traylor R, Bhalla K, McCrady C, Pettit G. Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells. Leukemia. 1992;6:432–9.

    Google Scholar 

  • Greenberg PL, VanKersen I, Mosny S. Cytotoxic effects of 1-b-D-arabino-furanosyl-cytosine and 6-thioguanine in vitro on granulocytic progenitor cells. Cancer Res. 1976;36:4412–7.

    Google Scholar 

  • Horikoshi A, Murphy MJ. Comparative effects of chemotherapeutic drugs on human and murine hematopoietic progenitors in vitro. Chemotherapy. 1982;28:480–501.

    Google Scholar 

  • Johnsson M, Caiazzo T, Molina JM, Donahue R, Groopman J. Inhibition of bone marrow myelopoiesis and erythropoiesis in vitro by antiretroviral nucleoside derivatives. Br J Haematol. 1988;70:137–41.

    Google Scholar 

  • Kelton JG, Huang AT, Mold N, Logue G, Rosse WF. The use of in vitro techniques to study drug-induced pancytopenia. N Engl J Med. 1979;301:621–4.

    Google Scholar 

  • Kerst JM, Slaper Cortenbach CM, von dem Borne AEGKR, Van Der Schoot C, Van Oers RHJ. Combined measurement of growth and differentiation in suspension cultures of purified human CD34 positive cells enabled a detailed analysis of myelopoiesis. Exp Hematol. 1992;20:1188–93.

    Google Scholar 

  • Kurtzberg J, Carter SG. Differential toxicity of carbovir and AZTT to human bone marrow hematopoietic progenitor cells. Exp Hematol. 1990;18:1094–6.

    Google Scholar 

  • Léglise MC, Darodes de Tailly P, Vignot JL, sawicki B, RIché C. Flow cytometric analysis of proliferation, differentiation and apoptotic parameters in a model of hematopoiesis in vitro applicable to pharmaco-toxicologic studies [abstract]. Cell Biol Toxicol. 1994;10:439.

    Google Scholar 

  • Lemoli RM, Gulati SC. In vitro cytotoxicity of VP-16–213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors. Exp Hematol. 1990;18:1008–12.

    Google Scholar 

  • Lista P, Brizzi MF, Rossi M, Resegotti Clark SC, Pegoraro L. Different sensitivity of normal and leukemic progenitor cells to Ara-C and IL-3 combined treatment. Br J Haematol. 1990;76:21–6.

    Google Scholar 

  • Mahmoud El Sayed Y, Sadée W. The fluoropyrimidines. In: Ames MM, Powis G, Kovach JS, eds. Pharmacokinetics of anticancer agents in humans. Amsterdam: Elsevier Science; 1983:209–30.

    Google Scholar 

  • Mayani H, Dragowska W, Landsorp M. Cytokine-indiced selective expansion and maturation of erythroid versus myeloid progenitors from purified cord blood precursor cells. Blood. 1993;12:3252–8.

    Google Scholar 

  • Metcalf D, MacDonald HR. Heterogeneity of in vitro colony and cluster forming cells in the mouse marrow — segregation by velocity sedimentation. J Cell Physiol. 1975;85:643–54.

    Google Scholar 

  • Okunewick JP, Buffo MJ, Kociban DL. Comparative toxicity of mitoxantrone and doxorubicin on hematopoietic stem cells. Exp Hematol. 1985;13:23–30.

    Google Scholar 

  • Parchment RE, Huang M, Erickson-Miller CL. Roles for in vitro myelotoxicity tests in preclinical drug development and clinical trial planning. Toxicol Pathol. 1993;21:241–50.

    Google Scholar 

  • Parent-Massin DM, Sensebé L, Léglise MC et al. Relevance of in vitro studies of drug-induced agranulocytosis. Report of 14 cases. Drug Safety. 1993;9:463–9.

    Google Scholar 

  • Patton WN, Duffull SB. Idiosyncratic drug-induced haematological abnormalities. Drug Safety. 1994;12: 445–62.

    Google Scholar 

  • Rajantie J, Kajosari M, Ylitalo V. Fatal pancytopenia during high-dose valproate monotherapy. Eur J Pediatr. 1992;15:619–20.

    Google Scholar 

  • Saeland S, Caux C, Favre C et al. Effects of recombinant interleukin-3 on CD34-enriched normal hematopoietic progenitors and on myeloblastic leukemia cells. Blood. 1988;72:1680–8.

    Google Scholar 

  • Safa Kaya I, Dilmen U, Tppare M, Alisenses D. Valproic acid-induced pancytopenia and Coombs test positivity [letter]. Lancet. 1991;337:1227–8.

    Google Scholar 

  • Sardonini CA, Ying-Jye WU. Expansion and differentiation of human hematopoietic cells from static cultures through small-scale bioreactors. Biotechnol Prog. 1993;9:131–7.

    Google Scholar 

  • Sato S, White BG, Penry JK, Dreifuss, Sackellares JC, Kupferberg HJ. Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology. 1982;32:157–63.

    Google Scholar 

  • Scadden DT, Wang A, Zsebo KM, Groopman JE. In vitro effects of stem-cell factor or interleukin-3 on myelosuppression associated with AIDS. AIDS. 1994;8:193–6.

    Google Scholar 

  • Schnabel R, Rambek B, Janssen F. Fatal intoxication with sodium valproate [letter]. Lancet. 1984; 28:221–2.

    Google Scholar 

  • Schlunck T, Schleyer M. The influence of culture conditions on the production of colony stimulating activity by human placenta. Exp Hematol. 1980;8:179–84.

    Google Scholar 

  • Smeland EB, Funderud S, Kalheim G et al. Isolation and characterization of human hematopoietic progenitor cells: an effective method for positive selection of CD34+ cells. Leukemia. 1992;6:845–52.

    Google Scholar 

  • Sommadossi JP, Carlisle R. Toxicity of 3′-azido-3′-deoxythymidine and 9-(dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitors cells in vitro. Antimicrob Agents Chemother. 1987;31:452–4.

    Google Scholar 

  • Speth PAJ, Raijmakers RAP, Boezeman JBM et al. In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cells. Eur J Cancer Clin Oncol. 1988;24:667.

    Google Scholar 

  • Srour EF, Brandt JE, Bridell RA, Leemhuis T, Van Besien K, Hoffman R. Human CD34 HLA-DR-bone marrow cells contain progenitors cells capable of self renewal, multi-lineage differentiation, and long term in vitro hematopoiesis. Blood Cells. 1991;17:287–95.

    Google Scholar 

  • Sungur C, Sungur A, Akpolat T, Yasavul U, Turgan C, Caglar S. Unresponsiveness to human recombinant erythropoietin in an epileptic dialysis patient secondary to valproic acid toxicity [letter]. Ann Pharmacother. 1992;26:1156.

    Google Scholar 

  • Terstappen LWMM, Buescher S, Nguyen M, Reading L. Differentiation and maturation of growth factor expanded human hematopoietic progenitors assessed by multi-dimensional flow cytometry. Leukemia. 1992;6:1001–10.

    Google Scholar 

  • Thierry D, Hervatin F, Traineau R et al. Hematopoietic progenitors cells in cord blood. Bone Marrow Transplant. 1992;10(Suppl.1):101–5.

    Google Scholar 

  • Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 1961;14:213–22.

    Google Scholar 

  • Tohda S, Nagata K, Suzuki T, Nara N. Comparative effects of busulfan, cytosine arabinoside and adriamycine on different maturation stages of normal human bone marrow cells. Acta Haematol. 1990;83:16–21.

    Google Scholar 

  • Turner CW, Cuzins J, Hutcheson C. A modified harvest technique for cord blood hematopoietic stem cells. Bone Marrow Transplant. 1992;10:89–91.

    Google Scholar 

  • Volpe DA, De Lin D, Pohl K, Campbell JP, Murphy MJ. Utility of human bone-marrow obtained incidental to orthopedic surgery for hematopoietic clonal assays. Pathobiology. 1991;59:53–6.

    Google Scholar 

  • Volpe DA, De Lin D, Verhoeef V, Murphy MJ. Myelotoxicity of ribafutin and 3′-azido-3′-deoxythymidine, alone and in combination to human hematopoietic progenitor cells in vitro. Phatobiology. 1993;61:77–82.

    Google Scholar 

  • Wagner JE. Isolation of primitive hematopoietic stem cells. Bone Marrow Transplant. 1992;25:6–9.

    Google Scholar 

  • Watts RG, Emanuel PD, Zuckerman KS, Howard TH. Valproic acid-induced cytopenias: evidence for a dose-related suppression of hematopoiesis. J Pediatr. 1990;117:495–9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire d'Hématologie, Centre Hospitalier Universitaire A. Morvan, Brest

    M. C. Léglise & A.-M. Le Roux

  2. Service de Pharmacologie, Centre Hospitalier Universitaire A. Morvan, Brest

    M. C. Léglise, P. Darodes de Tailly, J. L. Vignot, M. A. Le Bot & C. Riché

  3. Hôpital d'Instruction des Armées Clermont-Tonnerre, Brest, France

    P. Darodes de Tailly & J. L. Vignot

Authors
  1. M. C. Léglise
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Darodes de Tailly
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. L. Vignot
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. A. Le Bot
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A.-M. Le Roux
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Riché
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Léglise, M.C., de Tailly, P.D., Vignot, J.L. et al. A cellular model for drug interactions on hematopoiesis: The use of human umbilical cord blood progenitors as a model for the study of drug-related myelosuppression of normal hematopoiesis. Cell Biol Toxicol 12, 39–53 (1996). https://doi.org/10.1007/BF00143393

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00143393

Keywords

Search

Navigation